United States - English - NLM (National Library of Medicine)

lupin limited - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95), zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s), abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - lamivudine 150 mg - abacavir, lamivudine and zidovudine tablet is indicated in combination with other antiretrovirals or alone for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. limitations of use: - limited data exist on the use of abacavir, lamivudine and zidovudine tablets alone in patients with higher baseline viral load levels (greater than 100,000 copies per ml) [see clinical studies (14)] . abacavir, lamivudine and zidovudine tablets are contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)]. - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)], lamivudine, or zidovudine. - with moderate or severe hepatic impairment [see use in specific populations (8.7)] . teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of abacavir, lamivudine and zidovudine tablets in pregnant women. reproduction studies with abacavir, lamivudine, and zidovudine have been p

Kenya - English - Pharmacy and Poisons Board

anhui biochem bio-pharmaceutical co., ltd no. 30 hongfeng road, hi-tech development zone, - zidovudine 300mg and lamivudine 150mg tablets - film-coated tablet - zidovudine 300mg and lamivudine 150mg tablets - antivirals for systemic use: combinations of

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - abacavir; lamivudine - film-coated tablet - 600/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - abacavir; lamivudine - film-coated tablet - 600/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - abacavir; lamivudine - film-coated tablet - 600/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - abacavir; lamivudine - film-coated tablet - 600 mg/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir

United States - English - NLM (National Library of Medicine)

a-s medication solutions - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95), zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - lamivudine and zidovudine tablet, usp a combination of two nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (hiv-1) infection.    lamivudine and zidovudine tablets are contraindicated in patients with a previous hypersensitivity reaction to lamivudine or zidovudine. pregnancy category c. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lamivudine and zidovudine tablets during pregnancy. physicians are encouraged to register patients by calling the antiretroviral pregnancy registry at 1-800-258-4263. fetal risk summary: there are no adequate and well-controlled trials of lamivudine and zidovudine tablet in pregnant women. clinical trial data demonstrate that maternal zidovudine treatment during pregnancy reduces vertical transmission of hiv-1 infection to the fetus. animal reproduction studies performed with lamivudine and zidovudine showed incre

Malta - English - Medicines Authority

generics uk limited - lamivudine - film-coated tablet - lamivudine 300 mg - antivirals for systemic use

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lamivudine -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lamivudine -